Active 0 6 0 6 O
bacterial 7 16 7 16 B-chronic_disease
infection 17 26 17 26 I-chronic_disease
within 27 33 27 33 O
one 34 37 34 37 B-upper_bound
week 38 42 38 42 I-upper_bound
of 43 45 43 45 O
hematopoietic 46 59 46 59 B-treatment
cell 60 64 60 64 I-treatment
transplant 65 75 65 75 I-treatment
( 76 77 76 77 I-treatment
HCT 77 80 77 80 I-treatment
) 80 81 80 81 I-treatment

Active 0 6 82 88 B-chronic_disease
fungal 7 13 89 95 I-chronic_disease
infection 14 23 96 105 I-chronic_disease
at 24 26 106 108 O
time 27 31 109 113 O
of 32 34 114 116 O
HCT 35 38 117 120 B-treatment

Acute 0 5 121 126 B-cancer
myelogenous 6 17 127 138 I-cancer
leukemia 18 26 139 147 I-cancer
( 27 28 148 149 I-cancer
AML 28 31 149 152 I-cancer
) 31 32 152 153 I-cancer
or 33 35 154 156 O
history 36 43 157 164 O
of 44 46 165 167 O
AML 47 50 168 171 O

Cardiac 0 7 172 179 O
: 7 8 179 180 O
ejection 9 17 181 189 B-clinical_variable
fraction 18 26 190 198 I-clinical_variable
> 27 28 199 200 O
45 28 30 200 202 B-lower_bound
% 30 31 202 203 I-lower_bound

Early 0 5 204 209 O
myelodysplastic 6 21 210 225 B-cancer
syndrome 22 30 226 234 I-cancer
, 30 31 234 235 I-cancer
with 32 36 236 240 I-cancer
multilineage 37 49 241 253 I-cancer
dysplasia 50 59 254 263 I-cancer
with 60 64 264 268 O
< 65 66 269 270 O
5 67 68 271 272 B-upper_bound
% 68 69 272 273 I-upper_bound
blasts 70 76 274 280 B-clinical_variable
, 76 77 280 281 O
with 78 82 282 286 O
or 83 85 287 289 O
without 86 93 290 297 O
chromosomal 94 105 298 309 O
anomalies 106 115 310 319 O

Hepatic 0 7 320 327 O
: 7 8 327 328 O
no 9 11 329 331 O
clinical 12 20 332 340 O
evidence 21 29 341 349 O
of 30 32 350 352 O
hepatic 33 40 353 360 B-chronic_disease
failure 41 48 361 368 I-chronic_disease
( 49 50 369 370 O
e.g. 50 54 370 374 O
coagulopathy 55 67 375 387 B-chronic_disease
, 67 68 387 388 O
ascites 69 76 389 396 B-chronic_disease
) 76 77 396 397 O

Hgb 0 3 398 401 B-clinical_variable
< 4 5 402 403 O
8 5 6 403 404 B-upper_bound
g 7 8 405 406 I-upper_bound
/ 8 9 406 407 I-upper_bound
dL 9 11 407 409 I-upper_bound

Hgb 0 3 410 413 B-clinical_variable
< 4 5 414 415 O
9 5 6 415 416 B-upper_bound
g 7 8 417 418 I-upper_bound
/ 8 9 418 419 I-upper_bound
dL 9 11 419 421 I-upper_bound

In 0 2 422 424 O
patients 3 11 425 433 O
18 12 14 434 436 B-lower_bound
- 14 15 436 437 O
60 15 17 437 439 B-upper_bound
years 18 23 440 445 I-upper_bound
of 24 26 446 448 O
age 27 30 449 452 B-age
, 30 31 452 453 O
moderately 32 42 454 464 O
severe 43 49 465 471 B-chronic_disease
aplastic 50 58 472 480 I-chronic_disease
anemia 59 65 481 487 I-chronic_disease
is 66 68 488 490 O
defined 69 76 491 498 O
as 77 79 499 501 O
having 80 86 502 508 O
at 87 89 509 511 O
least 90 95 512 517 O
one 96 99 518 521 B-lower_bound

In 0 2 522 524 O
patients 3 11 525 533 O
< 12 13 534 535 O
18 13 15 535 537 B-upper_bound
years 16 21 538 543 I-upper_bound
of 22 24 544 546 O
age 25 28 547 550 B-age
, 28 29 550 551 O
moderately 30 40 552 562 B-chronic_disease
severe 41 47 563 569 I-chronic_disease
aplastic 48 56 570 578 I-chronic_disease
anemia 57 63 579 585 I-chronic_disease
is 64 66 586 588 O
defined 67 74 589 596 O
as 75 77 597 599 O
having 78 84 600 606 O
at 85 87 607 609 O
least 88 93 610 615 O
one 94 97 616 619 O

Karnofsky 0 9 620 629 B-clinical_variable
performance 10 21 630 641 I-clinical_variable
status 22 28 642 648 I-clinical_variable
> 29 30 649 650 O
70 30 32 650 652 B-lower_bound
% 32 33 652 653 I-lower_bound
or 34 36 654 656 O
Lansky 37 43 657 663 B-clinical_variable
> 44 45 664 665 O
50 45 47 665 667 B-lower_bound
% 47 48 667 668 I-lower_bound

Late 0 4 669 673 O
MDS 5 8 674 677 B-clinical_variable
with 9 13 678 682 O
greater 14 21 683 690 O
than 22 26 691 695 O
5 27 28 696 697 B-lower_bound
% 28 29 697 698 I-lower_bound
blasts 30 36 699 705 O
in 37 39 706 708 O
bone 40 44 709 713 O
marrow 45 51 714 720 O

Malignant 0 9 721 730 B-cancer
solid 10 15 731 736 I-cancer
tumor 16 21 737 742 I-cancer
( 22 23 743 744 O
e.g. 23 27 744 748 O
squamous 28 36 749 757 B-cancer
cell 37 41 758 762 I-cancer
carcinoma 42 51 763 772 I-cancer
of 52 54 773 775 I-cancer
the 55 58 776 779 I-cancer
head 59 63 780 784 I-cancer
/ 63 64 784 785 I-cancer
neck 64 68 785 789 I-cancer
/ 68 69 789 790 I-cancer
cervix 69 75 790 796 I-cancer
) 75 76 796 797 O
within 77 83 798 804 O
2 84 85 805 806 B-upper_bound
years 86 91 807 812 I-upper_bound
of 92 94 813 815 O
HCT 95 98 816 819 B-treatment

Patients 0 8 820 828 O
must 9 13 829 833 O
be 14 16 834 836 O
< 17 18 837 838 O
60 18 20 838 840 B-upper_bound
years 21 26 841 846 I-upper_bound
of 27 29 847 849 O
age 30 33 850 853 B-age
with 34 38 854 858 O
a 39 40 859 860 O
diagnosis 41 50 861 870 O
of 51 53 871 873 O
Fanconi 54 61 874 881 B-chronic_disease
Anemia 62 68 882 888 I-chronic_disease
( 69 70 889 890 I-chronic_disease
FA 70 72 890 892 I-chronic_disease
) 72 73 892 893 I-chronic_disease

Patients 0 8 894 902 O
must 9 13 903 907 O
have 14 18 908 912 O
an 19 21 913 915 O
HLA 22 25 916 919 B-clinical_variable
- 25 26 919 920 I-clinical_variable
A 26 27 920 921 I-clinical_variable
, 27 28 921 922 I-clinical_variable
B 29 30 923 924 I-clinical_variable
, 30 31 924 925 O
DRB1 32 36 926 930 B-clinical_variable
identical 37 46 931 940 O
sibling 47 54 941 948 O
donor 55 60 949 954 O

Patients 0 8 955 963 O
with 9 13 964 968 O
FA 14 16 969 971 B-chronic_disease
must 17 21 972 976 O
have 22 26 977 981 O
moderately 27 37 982 992 O
severe 38 44 993 999 O
aplastic 45 53 1000 1008 B-chronic_disease
anemia 54 60 1009 1015 I-chronic_disease
( 61 62 1016 1017 I-chronic_disease
AA 62 64 1017 1019 I-chronic_disease
) 64 65 1019 1020 I-chronic_disease
, 65 66 1020 1021 O
early 67 72 1022 1027 O
myelodysplastic 73 88 1028 1043 B-cancer
syndrome 89 97 1044 1052 I-cancer
( 98 99 1053 1054 I-cancer
MDS 99 102 1054 1057 I-cancer
) 102 103 1057 1058 I-cancer
with 104 108 1059 1063 O
no 109 111 1064 1066 O
excess 112 118 1067 1073 O
blasts 119 125 1074 1080 O
with 126 130 1081 1085 O
or 131 133 1086 1088 O
without 134 141 1089 1096 O
chromosomal 142 153 1097 1108 B-chronic_disease
abnormalities 154 167 1109 1122 I-chronic_disease

Pregnant 0 8 1123 1131 B-pregnancy

Women 0 5 1132 1137 B-gender
of 6 8 1138 1140 O
child 9 14 1141 1146 O
bearing 15 22 1147 1154 O
age 23 26 1155 1158 B-age
must 27 31 1159 1163 O
be 32 34 1164 1166 O
using 35 40 1167 1172 B-contraception_consent
adequate 41 49 1173 1181 I-contraception_consent
birth 50 55 1182 1187 I-contraception_consent
control 56 63 1188 1195 I-contraception_consent
and 64 67 1196 1199 O
have 68 72 1200 1204 O
a 73 74 1205 1206 O
negative 75 83 1207 1215 B-pregnancy
pregnancy 84 93 1216 1225 I-pregnancy
test 94 98 1226 1230 O

absolute 0 8 1231 1239 B-clinical_variable
neutrophil 9 19 1240 1250 I-clinical_variable
count 20 25 1251 1256 I-clinical_variable
( 26 27 1257 1258 I-clinical_variable
ANC 27 30 1258 1261 I-clinical_variable
) 30 31 1261 1262 I-clinical_variable
< 32 33 1263 1264 O
10 33 35 1264 1266 B-upper_bound
x 36 37 1267 1268 I-upper_bound
10 38 40 1269 1271 I-upper_bound
^ 40 41 1271 1272 I-upper_bound
8 41 42 1272 1273 I-upper_bound
/ 42 43 1273 1274 I-upper_bound
L 43 44 1274 1275 I-upper_bound

lactating 0 9 1276 1285 O
female 10 16 1286 1292 B-gender

platelet 0 8 1293 1301 B-clinical_variable
count 9 14 1302 1307 I-clinical_variable
< 15 16 1308 1309 O
40 16 18 1309 1311 B-upper_bound
x 19 20 1312 1313 I-upper_bound
10 21 23 1314 1316 I-upper_bound
^ 23 24 1316 1317 I-upper_bound
9 24 25 1317 1318 I-upper_bound
/ 25 26 1318 1319 I-upper_bound
L 26 27 1319 1320 I-upper_bound

